Home » Topics » BioWorld Science

BioWorld Science
RSS

Chinese investigators present adenosine A2A receptor antagonists

Sep. 2, 2019

Genifarm Laboratories and SCUT patent new compounds for cancer

Sep. 2, 2019

Novel organoid models cover a wide range of endometrial diseases

Sep. 2, 2019

Sunshine Lake Pharma discloses BIRC3 inhibitors

Sep. 2, 2019

Ancureall Biomedical Technology identifies CDK9 inhibitors

Sep. 2, 2019

MiR-125a-5p identified as tumor suppressor and biomarker in head and neck cancer

Sep. 2, 2019

Medshine Discovery divulges new KDM5A inhibitors

Sep. 2, 2019

New phase I trial to study gene therapy for APOE4 homozygotes with Alzheimer's disease

Sep. 2, 2019

Krystal Biotech initiates phase I/II study of topical KB-105 gene therapy for TGM1-deficient ARCI

Sep. 2, 2019

Synthetic oligosaccharide-protein conjugate N. meningitidis vaccine is immunogenic in vivo

Sep. 2, 2019

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...